Combined Targeted Analysis of Metabolites and Proteins in Tear Fluid With 
Regard to Clinical Applications

Dammeier, S; Martus, P; Klose, F; Seid, M; Bosch, D; D'Alvise, J; Ziemssen, F; Dimopoulos, S; Ueffing, M

doi:10.1167/tvst.7.6.22

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Combined Targeted Analysis of Metabolites and Proteins in Tear Fluid With Regard to Clinical Applications

MPS-Authors

There are no MPG-Authors in the publication available

External Resource

https://tvst.arvojournals.org/article.aspx?articleid=2718263
(Publisher version)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Dammeier, S., Martus, P., Klose, F., Seid, M., Bosch, D., D'Alvise, J., et al. (2018). Combined Targeted Analysis of Metabolites and Proteins in Tear Fluid With Regard to Clinical Applications. Translational Vision Science & Technology, 7(6): 22. doi:10.1167/tvst.7.6.22.

Cite as: https://hdl.handle.net/21.11116/0000-000C-9B51-A

Abstract

Purpose: To establish a robust workflow for combined mass spectrometry–based analysis of metabolites and proteins in tear fluid with regard to clinical applicability.
Methods: Tear fluid was taken from 12 healthy volunteers at different time points using specially designed Schirmer strips. Following the liquid extraction of metabolites from standardized punches, the remaining material was processed for bottom-up proteomics. Targeted metabolite profiling was performed adapting a metabolomics kit, which targets 188 metabolites from four different analyte classes. Proteomics was performed of the identical samples targeting 15 tear proteins relevant to ocular health.
Results: Sixty metabolites could be consistently determined in all tear samples (98 metabolites were detectable in average) covering acylcarnitines, amino acids, biogenic amines, and glycerophospholipids. Following normalization, the majority of metabolites exhibited intraindividual variances of less than 20%, both regarding different times of sampling, and the individual eye. The targeted analysis of tear proteins revealed a mean intraindividual variation of 23% for the three most abundant proteins. Even extreme differences in tear secretion rates resulted in interindividual variability below 30% for 65 metabolites and two proteins.
Conclusions: The newly established workflow can be used for combined targeted detection of metabolites and proteins in one punch of a Schirmer strip in a clinical setting.